Asundexian plus antiplatelet therapy reduces IS risk in patients with noncardioembolic stroke or high-risk transient ischemic attack.

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes ...

Fatigue, a common symptom immediately after a transient ischemic attack (TIA), persists up to a year after the event in 53.8% of patients, a new study showed. History of anxiety or depression was ...

Please provide your email address to receive an email when new articles are posted on . Liraglutide may improve outcomes and prognosis after minor stroke/transient ischemic attack in patients with ...